• The effectiveness of transdermally administered clonidine hydrochloride was evaluated in a multicenter study in 85 patients with mild essential hypertension. The drug was incorporated into small self-adhesive delivery systems (pliable skin patches, 3.5—sq-cm area) designed to continuously deliver 0.1 mg of clonidine hydrochloride per day. These devices were changed by the patients themselves at weekly intervals. Diastolic BP fell by at least 10% in 37 patients and was normalized (<90 mm Hg) in 54 patients (64%); 17 of these responding patients required only one skin patch, 27 required two, and the other ten responders required three. The antihypertensive action of the transdermal clonidine was sustained for the full three months of study. Side effects were similar to those during conventional oral treatment, but appeared to be milder.
(Arch Intern Med 1984;144:1211-1213)
Weber MA, Drayer JIM, McMahon FG, Hamburger R, Shah AR, Kirk LN. Transdermal Administration of Clonidine for Treatment of High BP. Arch Intern Med. 1984;144(6):1211–1213. doi:10.1001/archinte.1984.00350180139020
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: